BRITTANY YOUNG: Open Payments
NPI 1376322602 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 136 payments from 13 companies in 2025. Trend: 2023 $373 · 2024 $1,671 · 2025 $2,430
Food & beverage: $2,430
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $348 |
| Teva Pharmaceuticals USA, Inc. | 16 | $346 |
| Otsuka America Pharmaceutical, Inc. | 23 | $324 |
| Lundbeck LLC | 14 | $200 |
| Alkermes, Inc. | 8 | $163 |
| Axsome Therapeutics, Inc. | 9 | $163 |
| Janssen Pharmaceuticals, Inc | 13 | $161 |
| E.R. Squibb & Sons, L.L.C. | 10 | $158 |
| Vanda Pharmaceuticals Inc. | 4 | $117 |
Products named: INGREZZA, REXULTI, CAPLYTA, UZEDY, Auvelity, INVEGA SUSTENNA, COBENFY, ARISTADA.
Industry payments across TN — which companies pay providers there.
